Literature DB >> 11428033

Bogorol A produced in culture by a marine Bacillus sp. reveals a novel template for cationic peptide antibiotics.

T Barsby1, M T Kelly, S M Gagné, R J Andersen.   

Abstract

[figure: see text] Bogorol A (1), a novel peptide antibiotic active against MRSA and VRE, has been isolated from cultures of a marine Bacillus sp. collected in Papua New Guinea. The structure of bogorol A was elucidated by a combination of spectroscopic analyses and chemical degradation. Bogorol A illustrates a new structural template for "cationic peptide antibiotics".

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11428033     DOI： 10.1021/ol006942q

Source DB:  PubMed          Journal:  Org Lett        ISSN： 1523-7052            Impact factor:   6.005


  28 in total

Review 1.  Alternative sources of biologically active substances.

Authors:  V Bĕhal
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

Review 2.  Development of antibiotics and the future of marine microorganisms to stem the tide of antibiotic resistance.

Authors:  Noer Kasanah; Mark T Hamann
Journal:  Curr Opin Investig Drugs       Date:  2004-08

Review 3.  Marine pharmacology in 2001--2002: marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Mark T Hamann
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2005 Mar-Apr       Impact factor: 3.228

4.  Isolation and characterization of potential antibiotic producing actinomycetes from water and sediments of Lake Tana, Ethiopia.

Authors:  Gebreselema Gebreyohannes; Feleke Moges; Samuel Sahile; Nagappan Raja
Journal:  Asian Pac J Trop Biomed       Date:  2013-06

Review 5.  An Analysis of Biosynthesis Gene Clusters and Bioactivity of Marine Bacterial Symbionts.

Authors:  Nadarajan Viju; Stanislaus Mary Josephine Punitha; Sathianeson Satheesh
Journal:  Curr Microbiol       Date:  2021-05-26       Impact factor: 2.188

6.  Polyketide and nonribosomal peptide retro-biosynthesis and global gene cluster matching.

Authors:  Chris A Dejong; Gregory M Chen; Haoxin Li; Chad W Johnston; Mclean R Edwards; Philip N Rees; Michael A Skinnider; Andrew L H Webster; Nathan A Magarvey
Journal:  Nat Chem Biol       Date:  2016-10-03       Impact factor: 15.040

7.  Isolation and Structural Elucidation of Brevibacillin, an Antimicrobial Lipopeptide from Brevibacillus laterosporus That Combats Drug-Resistant Gram-Positive Bacteria.

Authors:  Xu Yang; En Huang; Chunhua Yuan; Liwen Zhang; Ahmed E Yousef
Journal:  Appl Environ Microbiol       Date:  2016-04-18       Impact factor: 4.792

8.  Antibacterial and antitumor activity of Bogorol B-JX isolated from Brevibacillus laterosporus JX-5.

Authors:  Hongxia Jiang; Chao Ji; Junkang Sui; Rongbo Sa; Xiaohui Wang; Xunli Liu; Tai L Guo
Journal:  World J Microbiol Biotechnol       Date:  2017-09-18       Impact factor: 3.312

9.  Anti-methicillin Resistant Staphylococcus aureus Compound Isolation from Halophilic Bacillus amyloliquefaciens MHB1 and Determination of Its Mode of Action Using Electron Microscope and Flow Cytometry Analysis.

Authors:  Venkadapathi Jeyanthi; Palaniyandi Velusamy
Journal:  Indian J Microbiol       Date:  2016-01-30       Impact factor: 2.461

Review 10.  Novel anti-infective compounds from marine bacteria.

Authors:  Hafizur Rahman; Brian Austin; Wilfrid J Mitchell; Peter C Morris; Derek J Jamieson; David R Adams; Andrew Mearns Spragg; Michael Schweizer
Journal:  Mar Drugs       Date:  2010-03-05       Impact factor: 5.118
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.